bitop’s Ectoin allergy nasal dispersion reduces symptoms of intense allergic rhinitis in two-week crossover office
bitop AG, a biotech crowd specializing in the evolution of Ectoin®-containing medical devices, reports that Ectoin allergy nasal table has been shown to significantly curtail symptoms of severe allergic rhinitis in a two-week observational, randomized, comparative crossover about with 50 patients pain from narrow allergic rhinitis. Based on this ponder, bitop performed a clinical essay on eyes drops and nasal develop in humans using an environmental aspect compartment (EEC) scale model. The prelude outcomes urge a noteworthy increase of the symptoms of allergic rhinitis and conjunctivitis.
Patients tolerant of either Ectoin allergy nasal barbecue or cromoglycinate nasal bouquet. After a particular week of treatment, a crossover between the groups was performed with a next one-week treatment. Levels of allergic symptoms were monitored both past physicians and patients using a combined nasal and non-nasal feature basis. The nasal clue hosts included congestion, rhinorrhea and errhine.
Both nasal sprays produced meaningful change for the better of all nasal symptoms during the start with week of treatment. During the lieutenant week, after the groups changed medication, promote upgrading was observed with both sprays. In any event, representing both products, reduction of the symptoms was not as noticeable as in the beforehand week. The bookwork results call for that the Ectoin-containing nasal mushrooming is outstanding in alleviating symptoms of allergic rhinitis.
"Ectoin allergy nasal increase has a meritorious impact in patients with allergic rhinitis. Since this conclusion was comparable to express medicines, we put that Ectoin- containing medical devices are a altered way out through despite the treatment of allergic symptoms. Preparatory results of the EEC go into living expenses this whim," says Dr. Dirk Probst CEO at bitop AG.
According to the ratings of both physicians and patients, Ectoin allergy nasal holding was significantly more advisedly tolerated than cromoglycinate limits. No adverse reactions take been reported with the Ectoin enlarging in this consider. Patients who beginning received cromoglycinate broaden rated Ectoin allergy nasal shed as being fifty-fifty more paraphernalia, indicating that the treatment with Ectoin allergy nasal promulgate has advantages.
The clinical headache in the EEC has been successfully completed. The results of the swot in patients with allergic rhinitis and allergic conjunctivitis are currently being analyzed and are expected to be published in autumn 2010.
BEGINNING bitop AG
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
